Insulin resistant phenotype of polycystic ovary syndrome does not seem to be caused by variation in FTO

Hormone and Metabolic Research

Volumn 44, Issue 11, 2012, Pages 810-813

  Hatziagelaki, E ^a   Wagner, R ^b   Kantartzis, K ^b   Heni, M ^b   Linder, K ^b   Ketterer, C ^b   MacHicao, F ^b   Stefan, N ^b   Staiger, H ^b   Haring H U ^b   Fritsche, A ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

FTO; insulin resistance; matched case control study; polycystic ovary syndrome (PCOS)

Indexed keywords

FTO PROTEIN; INSULIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; COHORT STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; YOUNG ADULT;

EID: 84867335534     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1321817     Document Type: Article

References (30)

1. Haupt A., Thamer C., Staiger H., Tschritter O., Kirchhoff K., Machicao F., Häring H-U, Stefan N., Fritsche A. Variation in the FTO gene influences food intake but not energy expenditure. Exp Clin Endocrinol Diabetes: 2009; 117 194 197
2. Haupt A., Thamer C., Machann J., Kirchhoff K., Stefan N., Tschritter O., Machicao F., Schick F., Häring H-U, Fritsche A. Impact of variation in the FTO gene on whole body fat distribution, ectopic fat, and weight loss. Obesity (Silver Spring): 2008; 16 1969 1972
3. Barber T. M., Bennett A. J., Groves C. J., Sovio U., Ruokonen A., Martikainen H., Pouta A., Hartikainen A-L, Elliott P., Lindgren C. M., Freathy R. M., Koch K., Ouwehand W. H., Karpe F., Conway G. S., Wass JA H., Järvelin M-R, Franks S., McCarthy M. I. Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome. Diabetologia: 2008; 51 1153 1158
4. Ewens K. G., Jones M. R., Ankener W., Stewart D. R., Urbanek M., Dunaif A., Legro R. S., Chua A., Azziz R., Spielman R. S., Goodarzi M. O., Strauss J. F. 3rd. FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS ONE: 2011; 6 e16390
5. Tschritter O., Preissl H., Yokoyama Y., Machicao F., Häring H-U, Fritsche A. Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia: 2007; 50 2602 2603
6. Grunnet L. G., Brons C., Jacobsen S., Nilsson E., Astrup A., Hansen T., Pedersen O., Poulsen P., Quistorff B., Vaag A. Increased recovery rates of phosphocreatine and inorganic phosphate after isometric contraction in oxidative muscle fibers and elevated hepatic insulin resistance in homozygous carriers of the A-allele of FTO rs9939609. J Clin Endocrinol Metab: 2009; 94 596 602
7. Kring SI I., Holst C., Zimmermann E., Jess T., Berentzen T., Toubro S., Hansen T., Astrup A., Pedersen O., Sorensen TI A. FTO gene associated fatness in relation to body fat distribution and metabolic traits throughout a broad range of fatness. PLoS ONE: 2008; 3 e2958
8. Ehrmann D. A., Barnes R. B., Rosenfield R. L., Cavaghan M. K., Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care: 1999; 22 141 146
9. Vink J. M., Sadrzadeh S., Lambalk C. B., Boomsma D. I. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab: 2006; 91 2100 2104
10. Chen Z-J, Zhao H., He L., Shi Y., Qin Y., Shi Y., Li Z., You L., Zhao J., Liu J., Liang X., Zhao X., Zhao J., Sun Y., Zhang B., Jiang H., Zhao D., Bian Y., Gao X., Geng L., Li Y., Zhu D., Sun X., Xu J., Hao C., Ren C., Zhang Y., Chen S., Zhang W., Yang A., Yan J., Li Y., Ma J., Zhao Y. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet: 2011; 43 55 59
11. Goodarzi M. O., Dumesic D. A., Chazenbalk G., Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol: 2011; 7 219 231
12. Nestler J. E., Jakubowicz D. J., de Vargas A. F., Brik C., Quintero N., Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab: 1998; 83 2001 2005
13. Nestler J. E., Powers L. P., Matt D. W., Steingold K. A., Plymate S. R., Rittmaster R. S., Clore J. N., Blackard W. G. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab: 1991; 72 83 89
14. Stefan N., Kantartzis K., Machann J., Schick F., Thamer C., Rittig K., Balletshofer B., Machicao F., Fritsche A., Häring H-U. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med: 2008; 168 1609 1616
15. Kantartzis K., Machann J., Schick F., Rittig K., Machicao F., Fritsche A., Häring H-U, Stefan N. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia: 2011; 54 864 868
16. Yildiz B. O., Knochenhauer E. S., Azziz R. Impact of obesity on the risk for polycystic ovary syndrome. J Clin Endocrinol Metab: 2008; 93 162 168
17. Diamanti-Kandarakis E., Kouli C. R., Bergiele A. T., Filandra F. A., Tsianateli T. C., Spina G. G., Zapanti E. D., Bartzis M. I. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab: 1999; 84 4006 4011
18. Azziz R., Woods K. S., Reyna R., Key T. J., Knochenhauer E. S., Yildiz B. O. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab: 2004; 89 2745 2749
19. Asunción M., Calvo R. M., San Millán J. L., Sancho J., Avila S., Escobar-Morreale H. F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab: 2000; 85 2434 2438
20. Yan Q., Hong J., Gu W., Zhang Y., Liu Q., Su Y., Zhang Y., Li X., Cui B., Ning G. Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women. Endocrine: 2009; 36 377 382
21. Attaoua R., Ait El Mkadem S., Radian S., Fica S., Hanzu F., Albu A., Gheorghiu M., Coculescu M., Grigorescu F. FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome. Biochem Biophys Res Commun: 2008; 373 230 234
22. Haap M., Machicao F., Stefan N., Thamer C., Tschritter O., Schnuck F., Wallwiener D., Stumvoll M., Häring H-U, Fritsche A. Genetic determinants of insulin action in polycystic ovary syndrome. Exp Clin Endocrinol Diabetes: 2005; 113 275 281
23. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod: 2004; 19 41 47
24. Matsuda M. Measuring and estimating insulin resistance in clinical and research settings. Nutr Metab Cardiovasc Dis: 2010; 20 79 86
25. Matthews D. R., Hosker J. P., Rudenski A. S., Naylor B. A., Treacher D. F., Turner R. C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia: 1985; 28 412 419
26. Kim J. J., Choi Y. M., Cho Y. M., Hong M. A., Chae S. J., Hwang K. R., Hwang S. S., Yoon S. H., Moon S. Y. Polycystic ovary syndrome is not associated with polymorphisms of the TCF7L2, CDKAL1, HHEX, KCNJ11, FTO and SLC30A8 genes. Clinical Endocrinology: 2012; [cited 2012 Apr 16]; Available from http://www.ncbi.nlm.nih.gov/pubmed/22443257
27. Saxena R., Welt C. K. Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes. Acta Diabetologica: 2012; [cited 2012 Apr 16]; Available from http://www.ncbi.nlm.nih.gov/pubmed/22389004
28. Kowalska I., Malecki M. T., Straczkowski M., Skupien J., Karczewska-Kupczewska M., Nikolajuk A., Szopa M., Adamska A., Wawrusiewicz-Kurylonek N., Wołczynski S., Sieradzki J., Gorska M. The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes. Diabetes Metab: 2009; 35 328 331
29. Tan S., Scherag A., Janssen O. E., Hahn S., Lahner H., Dietz T., Scherag S., Grallert H., Vogel CI G., Kimmig R., Illig T., Mann K., Hebebrand J., Hinney A. Large effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS). BMC Med Genet: 2010; 11 12
30. March W. A., Moore V. M., Willson K. J., Phillips DI W., Norman R. J., Davies M. J. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod: 2010; 25 544 551